Next-generation isotope production site aims to boost global supply and advance precision medicine
Philadelphia, Pennsylvania,24 March 2026 – TerraPower Isotopes has announced plans to build...
French pharmaceutical group expands precision oncology portfolio with promising pediatric brain cancer therapy
California, USA, 10 March 2026 - Global pharmaceutical company Servier has announced...
$23 billion US investment plan gains momentum as new center aims to accelerate AI-driven drug discovery and advanced therapies
San Diego, California, 12 February 2026...
DrugCLIP opens a new chapter in drug discovery with genome-scale virtual screening.
Beijing, China, 9 January 2026 – A new artificial intelligence system is changing...
AI-powered discovery platform EVA™ drives development of a highly selective T-cell engager showing over 90% tumor growth inhibition in pre-clinical studies.
London, 13 November 2025...
